William Blair reaffirmed their outperform rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report sent to investors on Monday morning, RTT News reports. A number of other equities analysts have also weighed in on ALNY. Citigroup decreased their target price on Alnylam Pharmaceuticals from $266.00 to $233.00 and set a […]
Forsta AP Fonden Purchases 500 Shares of Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty research firms that are covering the firm, Marketbeat reports. Seven analysts have rated the stock with a hold recommendation and thirteen have issued a buy recommendation on the company. The average 1 year price target among […]
Capital Group Private Client Services Inc. purchased a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 6,354 shares of the biopharmaceutical company’s stock, valued at approximately $1,207,000. Other institutional […]
HC Wainwright reissued their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a report published on Wednesday, Benzinga reports. The brokerage currently has a $395.00 price objective on the biopharmaceutical company’s stock. Other equities analysts also recently issued reports about the company. Sanford C. Bernstein dropped their price target on Alnylam […]